Browsing: Topics

47-6 Airway.png
The year of 2019 ushered in an abundance of interesting, practice-informing, and excellently conducted research regarding airway and peri-intubation management that is potentially applicable to the em
47-6 Gonococcal Arthritis - anchor.jpg
Septic arthritis is a rheumatologic emergency, which may lead to permanent joint damage and a mortality rate of 10-15%. If left untreated, non-gonococcal septic arthritis can destroy articular cartila
47-6 Subarachnoid Hemorrhage CT.jpg
Subarachnoid hemorrhage is a terrifying, relatively frequent cause of intracranial bleeding. It has a significant degree of morbidity and mortality - and therefore is a can't-miss diagnosis.
47-6 FUSS - Image 1.jpg
In 2018, statistics show 15,605 children and adolescents were confirmed victims of physical abuse in the United States. It is vital to ensure a safe disposition for pediatric patients, as further harm
47-6 Bells Palsy.jpg
Bell's palsy, also called idiopathic facial nerve palsy, is the paralysis of facial motor function without an identifiable cause. It typically presents with sudden onset unilateral facial paralysis an
47-6 New Board Nick Cozzi.jpg
Nicholas Cozzi, MD, MBA, of Spectrum Health/Michigan State University, has been selected as the next EMRA Representative to ACEP - advocating for the concerns and issues important to the EM trainee.
47-6 New Board Yev Maksimenko.jpg
Capt. Yev Maksimenko, MD, MA, DiMM, FAWM, FP-C, learned his leadership skills in the United States Air Force. Now he's pioneering a new role on the EMRA Board: Director of Leadership Development.
47-6 New Board Maggie Moran.jpg
In a year when health care policy is squarely in the spotlight, get to know new EMRA Board Director of Health Policy Maggie Moran, MD.
47-6 New Board Angela Cai.jpg
The EMRA Representative Council chose Angela Cai, MD, MBA, as EMRA President-elect in October. Get to know Dr. Cai.
47-6 New Board RJ Sontag.jpg
RJ Sontag, MD, inherited the gavel of EMRA President in October. Learn more about his goals, experience, and outlook.